Biolidics' Covid-19 rapid test kit allowed to be sold in EU
Vivienne Tay
Singapore
SINGAPORE-BASED cancer diagnos-tics company Biolidics on Monday said its rapid test kit for Covid-19 is allowed for sale in the European Union (EU).
This was after the test kit obtained confirmation for CE marking, a notification process to the relevant authority which allows the company to market and sell the kit in the EU. Having the CE marking confirms the test kit complies with the relevant EU product safety directives.
TRENDING NOW
Despite the de-dollarisation debate, demand for dollar liquidity in Asia is growing
URA to review guidelines on floor space to give developers more design flexibility: Chee Hong Tat
He built the Vingroup empire. Now South-east Asia’s richest man is handing some key roles to his sons
Can a first-time homebuyer couple earning S$18,000 a month afford a new EC unit?